banner

Perry W. Buffington – Psychopharmacology 2-Day Conference

img

Faculty:
Perry W. Buffington
Duration:
12 Hours 12 Minutes
Format:
Audio and Video
Copyright:
Sep 14, 2017

Description

Outline

DAY ONE

PSYCHOPHARMACOLOGY

  • Historical antecedents of modern psychopharmacology
  • Diagnostic issues
  • Clarification of terms
  • Drug metabolism concepts: pharmacokinetics & pharmacodynamics
  • Drug mechanism of action
  • Placebo & Nocebo
  • Pharmacotherapy vs. Pharmacotherapy
  • Developing highly effective collaborations with prescribers

DEPRESSIVE DISORDERS

  • Biogenic Amine, Cortisol, Down-Regulation, & Neurotropic Hypotheses
  • Neurochemistry of depression
  • Types of anti-depressants
  • Preventing side effects
  • Tardive Dysphoria: real or imagined?

ANXIETY DISORDERS & OBSESSIVE COMPULSIVE DISORDERS & TRAUMA RELATED DISORDERS

  • Neurochemistry of anxiety
  • GAD, panic disorders, phobias
  • OCD
  • PTSD
  • Physiological interventions
  • Anti-anxiety medications
  • Anti-depressants
  • Non-pharmacologic options
  • Benzodiazepines: risks and benefits
  • Preventing side effects

BIPOLAR DISORDERS

  • Neurochemistry
  • The Bipolar Spectrum & DSM-5® Changes
  • Mood stabilizers
    • Lithium
    • Anti-convulsants & neuromodulators
  • Typical, atypical, & third-generation antipsychotics
  • Effective strategies for improving outcomes for clients

PSYCHOTIC DISORDERS/ SCHIZOPHRENIA

  • Neurochemistry of psychosis and schizophrenia
  • Antipsychotic Medications:
    • First generation (typical)
    • Second generation (atypical)
  • Managing side effects
    • Extrapyramidal symptoms and TD
    • Metabolic problems- what blood tests are needed and when
    • Preventing Diabetes Mellitus
  • Recognizing hyperprolactinemia- and why you need to know
  • Use of atypical antipsychotics for multiple disorders

LIMITATIONS OF THE RESEARCH & POTENTIAL RISKS

DAY TWO

ATTENTIONAL DISORDERS

  • Differential diagnosis
  • Neurochemistry of ADHD
  • Treatment controversies
  • Substance abuse and ADHD
  • Stimulant medications
  • Non-stimulant options
  • Preventing side effects

SUBSTANCE ABUSE DISORDERS

  • Neurochemistry of addiction
  • Negative reinforcement & creation of habits
  • Alcohol
  • Caffeine
  • Nicotine
  • Cannabis
  • Opiates
  • PCP & Ketamine
  • MDMA (Ecstasy)
  • Energy vs. Chill Drinks
  • Over-the-counter & herbal psychopharmacology
  • Addiction treatments
  • Behavioral addictions

SPECIAL POPULATIONS

  • Specialized guidelines for geriatric patients
  • Dementia treatment
  • Slow vs. rapid metabolizers (genetic polymorphisms)

TREATING CLIENTS PAIN

  • Acute vs. chronic pain
  • Alternatives to pharmacology
  • Pain vs. depression: which comes first?

ETHICS & PSYCHOPHARMACOLOGY

  • High-risk pharmacology & psychopharmacology
  • Off-label use of medications
  • Prescribing for children
  • Elective psychopharmacology
  • Marketing of mental illness
  • Polypharmacy
  • Informed vs. uninformed consent
  • Patient & third party pressures
  • Professional boundaries
  • Ethics associated with medical errors
  • Role of placebo

FUTURE TRENDS

  • Change of mind: preventing vs. managing side effects
  • Medicalization of normal
  • Computer assisted devices
  • New meds, new diagnoses, new theories, new normal
  • Top 10 Medical Emergencies
  • Integrating psychotherapy with psychopharmacology

LIMITATIONS OF THE RESEARCH & POTENTIAL RISKS

Faculty

Perry W. Buffington, PH.D., MS Related seminars and products: 2


Perry Buffington, Ph.D., M.S., has over 20 years of experience in the medical consulting field and is currently a full-time senior lecturer at the University of Georgia, teaching psychopharmacology at the undergraduate and graduate levels. He is former chairman of the prestigious Florida Psychological Association’s Prescriptive Authority Committee and teaches seminars nationwide on minimizing psychopharmacological errors.

As the author of eight books (currently working on his first psychopharmacology text), his by-line has appeared in hundreds of periodicals including the Saturday Evening Post, USA Today, and Success. He is the former contributing editor for Delta Air Lines’ in-flight magazine, Sky, and served as a syndicated newspaper/web columnist for Universal Press. Additional, he hosted his own radio show, syndicated nationally, by Envison Radio Networks.

Perry’s presentation style is engaging, a blend of education and entertainment; as a result, critics (and especially his students) applaud his ability to make complicated topics understandable and applicable – even useful!!

Speaker Disclosures:

Financial: Perry Buffington is the President of Go-Buff Enterprises, Inc. He is a member of the psychology faculty, Franklin College of Arts & Sciences, The University of Georgia. Dr. Buffington receives a speaking honorarium from PESI, Inc.

Nonfinancial: Perry Buffington has no relevant nonfinancial relationship to disclose.


Salepage: https://catalog.pesi.com//item/psychopharmacology-2day-conference-24536
Archive: https://archive.ph/wip/TqeiF

Delivery Method

– After your purchase, you’ll see a View your orders link which goes to the Downloads page. Here, you can download all the files associated with your order.
– Downloads are available once your payment is confirmed, we’ll also send you a download notification email separate from any transaction notification emails you receivefrom coursesblock.com
– Since it is a digital copy, our suggestion is to download and save it to your hard drive. In case the link is broken for any reason, please contact us and we will resend the new download link.
– If you cannot find the download link, please don’t worry about that. We will update and notify you as soon as possible at 8:00 AM – 8:00 PM (UTC 8).

Thank You For Shopping With Us!

Original price was: $439.99.Current price is: $87.00.

[Instant Download] – You will receive instant download access after the purchase